CAT No: CP26201
CAS No:112913-63-0
Synonyms/Alias:112913-63-0;Fmoc-MeTrp-OH;Fmoc-Nalpha-methyl-L-tryptophan;Fmoc-N-Me-Trp-OH;Na-Fmoc-Na-methyl-L-tryptophan;(2S)-2-[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]-3-(1H-indol-3-yl)propanoic acid;(s)-2-((((9h-fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(1h-indol-3-yl)propanoic acid;(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl](methyl)amino}-3-(1H-indol-3-yl)propanoic acid;N-Fmoc-N-methyl-L-tryptophan;SCHEMBL3726968;L-Tryptophan, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-methyl-;Na-(((9H-fluoren-9-yl)methoxy)carbonyl)-Na-methyl-L-tryptophan;MFCD02682369;AKOS015837151;AS-83800;DB-234856;CS-0091374;D75117;L-Tryptophan,N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-methyl-;
1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
2. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.